⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MBRX News
Moleculin Biotech, Inc.
Form 8-K
sec.gov
MBRX
Moleculin to Showcase New Annamycin Data at AACR Conference on Pancreatic Cancer and Two European Scientific Meetings
globenewswire.com
MBRX
Moleculin Presentation from H.C. Wainwright Conference Now Available On-Demand
globenewswire.com
MBRX
Jennifer Stewart, CEO of Syntax Strategic, Named a 2026 Canada’s Most Powerful Women: Top 100 Award Winner
globenewswire.com
MBRX
Form 8-K
sec.gov
MBRX
Moleculin CEO, Walter Klemp, Participates in the Virtual Investor “Why Now” On-Demand Conference
globenewswire.com
MBRX
JTC Team Releases Virtual Investor "Why Now" On-Demand Conference Featuring Nine Public Company CEOs
accessnewswire.com
AIM
AKTX
CNSP
DARE
NVNO
ERNA
GRI
MBRX
OTLK
Form 8-K
sec.gov
MBRX
Moleculin Biotech Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of Pivotal MIRACLE Trial
globenewswire.com
MBRX
Form 8-K
sec.gov
MBRX